ArticleJournal of the American Heart Association2016

Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials.

Kengo Ayabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.